Clover Health Investments Corp. [CLOV] stock Upgrade by Cowen analyst, price target now $3

Clover Health Investments Corp. [NASDAQ: CLOV] loss -5.47% or -0.07 points to close at $1.21 with a heavy trading volume of 5151534 shares. The company report on January 10, 2023 that Clover Health Provides Business Update and Issues Partial Guidance for Full-Year 2023.


Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored


“2023 will be a pivotal year for Clover Health and I believe we will prove out the strength of our approach to managing care for Medicare beneficiaries. It’s an exciting time for me to transition into the role of Chief Executive Officer, working with our team to deliver results for our members, our physician network partners, and our shareholders”, said Andrew Toy, Chief Executive Officer of Clover Health.

It opened the trading session at $1.25, the shares rose to $1.29 and dropped to $1.19, the range by which the price of stock traded the whole day. The daily chart for CLOV points out that the company has recorded -53.46% loss over the past six months. However, it is still -40.7% lower than its most recent low trading price.

If we look at the average trading volume of 6.84M shares, CLOV reached to a volume of 5151534 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Clover Health Investments Corp. [CLOV]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLOV shares is $2.05 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLOV stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Cowen have made an estimate for Clover Health Investments Corp. shares, keeping their opinion on the stock as Market Perform, with their previous recommendation back on February 02, 2022. While these analysts kept the previous recommendation, Canaccord Genuity raised their target price to Buy. The new note on the price target was released on February 02, 2022, representing the official price target for Clover Health Investments Corp. stock. Previously, the target price had yet another raise to $3, while SVB Leerink analysts kept a Mkt Perform rating on CLOV stock. On January 10, 2022, analysts decreased their price target for CLOV shares from 9 to 3.50.

The Average True Range (ATR) for Clover Health Investments Corp. is set at 0.09, with the Price to Sales ratio for CLOV stock in the period of the last 12 months amounting to 0.18. The Price to Book ratio for the last quarter was 1.48, with the Price to Cash per share for the same quarter was set at 1.62.

Trading performance analysis for CLOV stock

Clover Health Investments Corp. [CLOV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.97. With this latest performance, CLOV shares gained by 24.34% in over the last four-week period, additionally sinking by -53.46% over the last 6 months – not to mention a drop of -52.17% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLOV stock in for the last two-week period is set at 55.26, with the RSI for the last a single of trading hit 56.87, and the three-weeks RSI is set at 51.82 for Clover Health Investments Corp. [CLOV]. The present Moving Average for the last 50 days of trading for this stock 1.1658, while it was recorded at 1.2300 for the last single week of trading, and 2.0985 for the last 200 days.

Clover Health Investments Corp. [CLOV]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and Clover Health Investments Corp. [CLOV] shares currently have an operating margin of -37.11. Clover Health Investments Corp.’s Net Margin is presently recorded at -38.21.

Return on Equity for this stock declined to -88.46, with Return on Assets sitting at -65.05.

Clover Health Investments Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.30 and a Current Ratio set at 1.30.

Clover Health Investments Corp. [CLOV]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLOV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Clover Health Investments Corp. go to 19.10%.

An analysis of insider ownership at Clover Health Investments Corp. [CLOV]

There are presently around $149 million, or 32.50% of CLOV stock, in the hands of institutional investors. The top three institutional holders of CLOV stocks are: VANGUARD GROUP INC with ownership of 30,910,067, which is approximately -3.692% of the company’s market cap and around 3.10% of the total institutional ownership; BLACKROCK INC., holding 25,887,235 shares of the stock with an approximate value of $31.32 million in CLOV stocks shares; and STATE STREET CORP, currently with $9.87 million in CLOV stock with ownership of nearly 2.579% of the company’s market capitalization.

Positions in Clover Health Investments Corp. stocks held by institutional investors increased at the end of February and at the time of the February reporting period, where 78 institutional holders increased their position in Clover Health Investments Corp. [NASDAQ:CLOV] by around 9,638,040 shares. Additionally, 65 investors decreased positions by around 9,174,217 shares, while 55 investors held positions by with 104,447,768 shares. The mentioned changes placed institutional holdings at 123,260,025 shares, according to the latest SEC report filing. CLOV stock had 20 new institutional investments in for a total of 1,446,288 shares, while 24 institutional investors sold positions of 2,001,266 shares during the same period.

LEAVE A REPLY

Please enter your comment!
Please enter your name here